Merle Ferguson is CEO of BIOFORCE NANOSCIENCES HOLDINGS, INC.. Currently has a direct ownership of 17.9 Million shares of BFNH, which is worth approximately $22.3 Million. The most recent transaction as insider was on Oct 18, 2023, when has been sold 1,400,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.9M
0% 3M change
19.13% 12M change
Total Value Held $22.3 Million

Merle Ferguson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 18 2023
BUY
Bona fide gift
-
1,400,000 Added 7.27%
17,870,000 Common Stock
Oct 17 2023
BUY
Bona fide gift
-
1,470,000 Added 8.19%
16,470,000 Common Stock
Dec 04 2020
BUY
Grant, award, or other acquisition
-
11,000,000 Added 42.31%
15,000,000 Common Stock

Also insider at

BRVO
Bravo Multinational Inc. Consumer Cyclical
GRHI
GOLD ROCK HOLDINGS, INC. Industrials
MF

Merle Ferguson

CEO
Encinitas, CA

Track Institutional and Insider Activities on BFNH

Follow BIOFORCE NANOSCIENCES HOLDINGS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BFNH shares.

Notify only if

Insider Trading

Get notified when an Bioforce Nanosciences Holdings, Inc. insider buys or sells BFNH shares.

Notify only if

News

Receive news related to BIOFORCE NANOSCIENCES HOLDINGS, INC.

Track Activities on BFNH